Salk's HIV immunogen: an immune-based therapy in human trials since 1988.
D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use; D017277:Drug Approval; D015658:HIV Infections / Q000628:therapy*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D016233:Immunotherapy, Active; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000627:therapeutic use
D016915:AIDS Vaccines; D015164:Vaccines, Inactivated